Terms: = Kidney tumors AND SMAD2, MADH2, 4087, ENSG00000175387, MGC34440, MGC22139, hMAD-2, MADR2, JV18-1, hSMAD2, JV18 AND Prognosis
3 results:
1. Downregulation of FXYD2 Is Associated with Poor prognosis and Increased Regulatory T Cell Infiltration in Clear Cell Renal Cell Carcinoma.
Zhang Z; Tang Y; Li L; Yang W; Xu Y; Zhou J; Ma K; Zhang K; Zhuang H; Gong Y; Gong K
J Immunol Res; 2022; 2022():4946197. PubMed ID: 36313180
[TBL] [Abstract] [Full Text] [Related]
2. Association of Abl interactor 2, ABI2, with platelet/lymphocyte ratio in patients with renal cell carcinoma: A pilot study.
Ergun S; Gunes S; Buyukalpelli R; Aydin O
Int J Exp Pathol; 2020 Jun; 101(3-4):87-95. PubMed ID: 32496656
[TBL] [Abstract] [Full Text] [Related]
3. Nuclear expression of Smad proteins and its prognostic significance in clear cell renal cell carcinoma.
Park JH; Lee C; Suh JH; Chae JY; Moon KC
Hum Pathol; 2013 Oct; 44(10):2047-54. PubMed ID: 23668999
[TBL] [Abstract] [Full Text] [Related]
